PMID- 29565168 OWN - NLM STAT- MEDLINE DCOM- 20180927 LR - 20181023 IS - 1699-5198 (Electronic) IS - 0212-1611 (Linking) VI - 35 IP - 1 DP - 2018 Jan 16 TI - Tissular growth factors profile after teduglutide administration on an animal model of intestinal anastomosis. PG - 185-193 LID - 10.20960/nh.1326 [doi] AB - BACKGROUND: Teduglutide is an enterotrophic analogue of glucagon-like peptide-2, with an indirect and poorly understood mechanism of action, approved for the rehabilitation of short-bowel syndrome. This study aims to analyze the response of tissue growth factors to surgical injury and teduglutide administration on an animal model of intestinal anastomosis. METHODS: Wistar rats (n = 59) were distributed into four groups: "ileal resection" or "laparotomy", each one subdivided into "postoperative teduglutide administration" or "no treatment"; and sacrificed at the third or the seventh day, with ileal sample harvesting. Gene expression of insulin-like growth factor 1 (Igf1), vascular endothelial growth factor a (Vegfa), transforming growth factor beta1 (Tgfbeta1), connective tissue growth factor (Ctgf), fibroblast growth factor 2 (Fgf2), fibroblast growth factor 7 (Fgf7), epidermal growth factor (Egf), heparin-binding epidermal-like growth factor (Hbegf), platelet-derived growth factor b (Pdgfb) and glucagon-like peptide 2 receptor (Glp2r)was studied by real-time polymerase chain reaction. RESULTS: Upregulation of Fgf7, Fgf2, Egf, Vegfaand Glp2rat the third day and of Pdgfat the seventh day was verified in the perianastomotic segment. Teduglutide administration was associated with higher fold-change of relative gene expression of Vegfa(3.6 +/- 1.3 vs.1.9 +/- 2.0, p = 0.0001), Hbegf(2.2 +/- 2.3 vs. 1.1 +/- 0.9, p = 0.001), Igf1(1.6 +/- 7.6 vs. 0.9 +/- 0.7, p = 0.002) and Ctgf(1.1 +/- 2.1 vs. 0.6 +/- 2.0, p = 0.013); and lower fold-change of Tgfbeta1, Fgf7and Glp2r. CONCLUSIONS: Those results underscore the recognized role of Igf1and Hbegfas molecular mediators of the effects of teduglutide and suggest that other humoral factors, like Vegfand Ctgf, may also be relevant in the perioperative context. Induction of Vegfa, Igf1and Ctgfgene expressions might indicate a favorable influence of teduglutide on the intestinal anastomotic healing. FAU - Costa, Beatriz Pinto AU - Costa BP AD - "A" Surgical Department, Hospitais da Universidade de Coimbra, Centro Hospitalar e Universitario de Coimbra, Coimbra, Portugal; Faculty of Medicine, University of Coimbra, Coimbra, Portugal. beatrizpcosta@iol.pt. FAU - Goncalves, Ana Cristina AU - Goncalves AC FAU - Abrantes, Ana Margarida AU - Abrantes AM FAU - Alves, Raquel AU - Alves R FAU - Matafome, Paulo AU - Matafome P FAU - Seica, Raquel AU - Seica R FAU - Sarmento-Ribeiro, Ana Bela AU - Sarmento-Ribeiro AB FAU - Botelho, Maria Filomena AU - Botelho MF FAU - Castro-Sousa, Francisco AU - Castro-Sousa F LA - eng PT - Journal Article TT - Perfil tisular de factores de crecimiento postadministracion de teduglutida en un modelo animal de anastomosis intestinal. DEP - 20180116 PL - Spain TA - Nutr Hosp JT - Nutricion hospitalaria JID - 9100365 RN - 0 (Gastrointestinal Agents) RN - 0 (Intercellular Signaling Peptides and Proteins) RN - 0 (Peptides) RN - 7M19191IKG (teduglutide) SB - IM MH - *Anastomosis, Surgical MH - Animals MH - Gastrointestinal Agents/*pharmacology MH - Gene Expression Regulation/drug effects MH - Ileum/metabolism/surgery MH - Intercellular Signaling Peptides and Proteins/biosynthesis/genetics/*metabolism MH - Intestines/*drug effects/*surgery MH - Male MH - Peptides/*pharmacology MH - Rats MH - Rats, Wistar MH - Short Bowel Syndrome EDAT- 2018/03/23 06:00 MHDA- 2018/09/28 06:00 CRDT- 2018/03/23 06:00 PHST- 2017/06/03 00:00 [received] PHST- 2017/07/21 00:00 [accepted] PHST- 2018/03/23 06:00 [entrez] PHST- 2018/03/23 06:00 [pubmed] PHST- 2018/09/28 06:00 [medline] AID - 10.20960/nh.1326 [doi] PST - epublish SO - Nutr Hosp. 2018 Jan 16;35(1):185-193. doi: 10.20960/nh.1326.